2015
DOI: 10.3201/eid2108.140956
|View full text |Cite
|
Sign up to set email alerts
|

Smallpox Vaccination of Laboratory Workers at US Variola Testing Sites

Abstract: To evaluate the need to revaccinate laboratory workers against smallpox, we assessed regular revaccination at the US Laboratory Response Network’s variola testing sites by examining barriers to revaccination and the potential for persistence of immunity. Our data do not provide evidence to suggest prolonging the recommended interval for revaccination.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
2
1
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…Recently, a third-generation vaccine developed from the Ankara strain of the modified attenuated vaccinia virus was approved for use in the prevention of monkeypox. The vaccine is marketed under the name JYNNEOOS [ 35 , 36 ]. Moreover, clinical studies for the VAC6 vaccine, a vaccination of the fourth generation, are now underway [ 37 ].…”
Section: Vaccinationmentioning
confidence: 99%
“…Recently, a third-generation vaccine developed from the Ankara strain of the modified attenuated vaccinia virus was approved for use in the prevention of monkeypox. The vaccine is marketed under the name JYNNEOOS [ 35 , 36 ]. Moreover, clinical studies for the VAC6 vaccine, a vaccination of the fourth generation, are now underway [ 37 ].…”
Section: Vaccinationmentioning
confidence: 99%